Enhabit, Inc. (EHAB) P/E Ratio History
Historical price-to-earnings valuation from 2022 to 2023
Loading P/E history...
EHAB Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Enhabit, Inc. (EHAB) trades at a price-to-earnings ratio of -152.1x, with a stock price of $13.78 and trailing twelve-month earnings per share of $-0.06.
The current P/E is 1380% below its 5-year average of 11.9x. Over the past five years, EHAB's P/E has ranged from a low of 8.3x to a high of 17.7x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, EHAB trades at a 781% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, EHAB trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our EHAB DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
EHAB P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 18.7 | 0.93Best | +23%Best | |
| $10B | 29.8 | 2.16 | +14% | |
| $2B | 13.9Lowest | - | -29% | |
| $1B | 42.5 | 4.23 | +18% | |
| $336B | 27.9 | - | -15% | |
| $30B | 25.1 | - | -1% | |
| $111B | 62.8 | - | -62% | |
| $81B | 14.8 | 2.15 | -2% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
EHAB Historical P/E Data (2022–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $13.91 | $0.78 | 17.7x | +49% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $13.16 | $1.25 | 10.5x | -11% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $14.04 | $1.70 | 8.3x | -30% |
| FY2022 Q2 | $22.97 | $2.09 | 11.0x | -7% |
Average P/E for displayed period: 11.9x
See EHAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EHAB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EHAB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEHAB — Frequently Asked Questions
Quick answers to the most common questions about buying EHAB stock.
Is EHAB stock overvalued or undervalued?
EHAB trades at -152.1x P/E, below its 5-year average of 11.9x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does EHAB's valuation compare to peers?
Enhabit, Inc. P/E of -152.1x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is EHAB's PEG ratio?
EHAB PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2023.